Respironics ( RESP - NASDAQ ) has just reported the last Q results . Part of RESPIRONICS biz is actually the second leg in the DUOPOLY of RMD/RESP in the APNEA sleep disorder market . Key drivers for the Company's domestic revenue performance include a year-over-year increase of 15 percent in domestic sleep therapy products. Let's hope RMD did the same . First call consensus expected increase for RMD is 12% in EPS growth .It is expected to report EPS USc 28 for the Q and USD 1.06 for the FY , Duff
- Forums
- ASX - By Stock
- RMD
- RMD - A possible profit clue
RMD - A possible profit clue
Add RMD (ASX) to my watchlist
|
|||||
Last
$27.49 |
Change
0.120(0.44%) |
Mkt cap ! $43.01B |
Open | High | Low | Value | Volume |
$27.68 | $27.70 | $27.47 | $12.66M | 459.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4644 | $27.48 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$27.53 | 31506 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4644 | 27.480 |
2 | 1645 | 27.460 |
2 | 4116 | 27.450 |
1 | 1328 | 27.440 |
2 | 4120 | 27.420 |
Price($) | Vol. | No. |
---|---|---|
27.530 | 31506 | 1 |
27.560 | 2913 | 2 |
27.590 | 5735 | 2 |
27.600 | 341 | 1 |
27.610 | 1584 | 1 |
Last trade - 16.10pm 19/01/2021 (20 minute delay) ? |
|
|||||
Last
$27.57 |
  |
Change
0.120 ( 0.55 %) |
|||
Open | High | Low | Volume | ||
$27.63 | $27.70 | $27.50 | 76048 | ||
Last updated 15.59pm 19/01/2021 (live) ? |
RMD (ASX) Chart |